RGC

Regencell Bioscience Holdings Limited NASDAQ Listed Jul 16, 2021

Healthcare ·Drug Manufacturers - Specialty & Generic ·HK · regencellbioscience.com

$31.66

Mkt Cap $15.7B

52w Low $5.30 33.7% of range 52w High $83.60

50d MA $27.07 200d MA $20.96

P/E (TTM) -4044.4x

EV/EBITDA -2639.6x

P/B 2971.4x

Debt/Equity 0.1x

ROE -73.8%

P/FCF -2579.7x

RSI (14) —

ATR (14) —

Beta 2.25

50d MA $27.07

200d MA $20.96

Avg Volume 155.4K

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

SIC Code

2833

CIK (SEC)

1829667

Phone

852 2155 0823

First Commercial Building · Causeway Bay KY1-1107 · HK

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Nov 18, 2025	AMC	—	-0.00	—	13.09	-0.9%	-1.7%	-3.6%	-4.7%	-10.8%	-13.8%	—
Jun 26, 2025	AMC	—	-0.14	—	20.19	-1.9%	-13.8%	-15.6%	-27.7%	-48.7%	+13.9%	—
Jan 26, 2024	AMC	—	0.00	—	0.22	-0.6%	-0.6%	-1.2%	-3.5%	-3.7%	-3.7%	—
Oct 27, 2023	AMC	—	-0.01	—	0.43	-1.8%	-3.9%	-2.3%	-13.9%	-13.4%	-13.9%	—
Jan 30, 2023	AMC	—	-0.01	—	0.75	+1.4%	+1.4%	+5.2%	+4.2%	+4.2%	+4.2%	—
Dec 30, 2021	AMC	—	-0.01	—	0.79	-0.0%	+6.1%	+2.0%	+14.6%	+6.6%	+16.6%	—
Dec 30, 2020	AMC	—	0.00	—	—	—	—	—	—	—	—	—
Jun 30, 2020	AMC	—	0.00	—	—	—	—	—	—	—	—	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 2	B. Riley	Downgrade	Buy → Neutral	—	—	—	—	—	—	—	—	—
Dec 6	Macquarie	Downgrade	Outperform → Neutral	—	—	—	—	—	—	—	—	—
Dec 6	Moffett Nathanson	Upgrade	Sell → Neutral	—	—	—	—	—	—	—	—	—
Dec 6	RBC Capital	Downgrade	Outperform → Perform	—	—	—	—	—	—	—	—	—

Data updated apr 26, 2026 10:38pm · Source: massive.com